echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Random Amplified Polymorphic DNA (RAPDs)

    Random Amplified Polymorphic DNA (RAPDs)

    • Last Update: 2020-11-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Because polymorphisms are noted by the presence or absence of amplification products from a single allele, the random amplified polymorphic
    DNA
    (RAPD) technique tends to provide only dominant markers. Individuals containing two copies of one allele are not distinguished by amplification (
    1
    ,
    2
    ) from those with only one copy. Dominant markers provide little linkage information for markers linked in repulsion. Therefore, when mapping, it is advisable to only work with markers linked in coupling, e.g., in a backcross or recombinant-inbred population, haploid, or gametophytic tissue or, alternately, in an F2 population with markers amplified from only one parent.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.